Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug resistance and mutagenesis

L R Ferguson1, B C Baguley

  • 1Cancer Research Laboratory, University of Auckland School of Medicine, New Zealand.

Mutation Research
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Promotion of the mediterranean diet incancer long-survivors by means of the Med-Food Anticancer Program: a pilot study.

Annali di igiene : medicina preventiva e di comunita·2018
Same author

"Five-A-Day" and the Med-Food Anticancer Program.

Annali di igiene : medicina preventiva e di comunita·2017
Same author

Dopamine transporter (DAT1/SLC6A3) polymorphism and the association between being born small for gestational age and symptoms of ADHD.

Behavioural brain research·2017
Same author

A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells.

Molecular bioSystems·2016
Same author

Differential modification of genetic susceptibility to childhood eczema by two probiotics.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Developmental changes through adolescence in the spontaneous nomination of reference groups as a function of decision content.

Journal of youth and adolescence·2013
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

Multidrug resistance (MDR) involves resistance to multiple drugs, often due to cellular efflux pumps. MDR-reversing agents can increase drug efficacy but may also enhance the mutagenicity of other compounds.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cell Biology

Background:

  • Multidrug resistance (MDR) is a phenomenon where cells become resistant to various drugs simultaneously.
  • This resistance is often linked to energy-dependent membrane transport systems that reduce intracellular drug concentrations.
  • MDR occurs naturally in mammalian tissues and bacteria, playing a role in cellular protection.

Purpose of the Study:

  • To explore the mechanisms and implications of multidrug resistance (MDR).
  • To investigate the role of MDR in modulating the mutagenic potential of chemical compounds.
  • To assess the safety and efficacy of MDR-reversing agents.

Main Methods:

  • Analysis of energy-dependent membrane transport systems.
  • Evaluation of MDR's effect on mutagenicity in mammalian and microbiological assays.

Related Experiment Videos

  • Assessment of MDR reversal by various compounds, including hydrophobic cations.

    • Main Results:

    • MDR can naturally reduce the mutagenic potential of compounds.
    • MDR-reversing agents, while not mutagenic themselves, can increase the mutagenicity of other substances.
    • This occurs by inhibiting protective MDR mechanisms within the body.

    Conclusions:

    • MDR is a complex biological process with implications for drug efficacy and toxicity.
    • MDR-reversing agents require careful consideration due to their potential to enhance compound mutagenicity.
    • Understanding MDR mechanisms is crucial for developing safer and more effective therapeutic strategies.